[Pneumocystis carinii pneumonia].
Division of Infectious Disease and Applied Immunology, Institute of Medical Science, Tokyo University.
Tetsuya
T
Nakamura
D017088:AIDS-Related Opportunistic Infections; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D007385:Intermittent Positive-Pressure Ventilation; D010419:Pentamidine / Q000008:administration & dosage; D011010:Pneumocystis / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D011239:Prednisolone / Q000008:administration & dosage; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage
D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011239:Prednisolone